Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
Time to buy GILD. Dropped too far. Remesvidir
Gilead Sciences, Inc.
Time to buy GILD. Dropped too far. Remesvidir
By hillsbr1
Follow
Follow
Oct 12, 2020
0
Oct 12, 2020
Time to buy GILD. Remesvidir and recently bounced off a low resistance of approximately $61.
Remesvidir recently was said to reduce recovery time from Covid-19. More info:
gilead.com/purpose/advancing-global-health/covid-19/about-veklury-remdesivir
Beyond Technical Analysis
Chart Patterns
Trend Analysis
hillsbr1
Follow
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.